PA
BSX icon

Persium Advisors’s Boston Scientific BSX Stock Holding History

Persium Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$843K Buy
19,308
+5,063
+36% +$234K 0.44% 46
2026
Q2 		$608K Buy
+14,245
New +$774K 0.4% 49

Other funds holding BSX

GI
Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
NPPM
North Point Portfolio Managers Orange Village, Ohio $595M AUM 14.89% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
NRS
Neville Rodie & Shaw New York $1.48B AUM 34.49% 1-Year Est. Return
QPBE
Quintet Private Bank (Europe) Luxembourg $2.28B AUM 23.89% 1-Year Est. Return
IRC
Investors Research Corp Atlanta, Georgia $569M AUM 15.41% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
VVP
Venture Visionary Partners Sylvania, Ohio $3.82B AUM 21.33% 1-Year Est. Return

Persium Advisors's BSX Position: Q3 2026 in Review

Persium Advisors increased its Boston Scientific (BSX) stake by 36% in Q3 2026, buying an estimated $234K and bringing the position to 19,308 shares worth $843K. The position accounts for 0.44% of the portfolio, ranked #46.

Persium Advisors first reported a position in BSX in Q2 2026 and has held it in 2 quarters since. 43 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Persium Advisors held 19,308 shares of Boston Scientific worth $843K as of Q3 2026.
  • Persium Advisors bought 5,063 Boston Scientific shares in Q3 2026, an estimated $234K.
  • Boston Scientific made up 0.44% of Persium Advisors's portfolio in Q3 2026, its #46 holding.
  • Persium Advisors first reported a position in Boston Scientific in Q2 2026 and has held it in 2 quarters since.
  • 43 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Persium Advisors's 13F filing for Q3 2026, filed 7 Oct 2026.